A021703
|
Alliance
|
Randomized Double-Blind Phase III Trial of Vitamin D3 Supplementation in Patients with Previously Untreated Metastatic Colorectal Cancer (SOLARIS)
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
A021804
|
Alliance
|
A Prospective, Multi-Institutional Phase II Trial Evaluating Temozolomide vs Temozolomide and Olaparib for Advanced Pheochromocytoma and Paraganglioma
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
A021806
|
Alliance
|
A Phase III Trial of Perioperative versus Adjuvant Chemotherapy for Resectable Pancreatic Cancer
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
A021901
|
Alliance
|
Randomized Phase II Trial of Lutetium Lu 177 Dotatate versus Everolimus in Somatostatin Receptor Positive Bronchial Neuroendocrine Tumors
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
A022001
|
Alliance
|
Phase II Randomized, Prospective Trial of Lutetium Lu 177 Dotatate PRRT Versus Capecitabine and Temozolomide in Well-Differentiated Pancreatic Neuroendocrine Tumors
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
A022004
|
Alliance
|
Randomized Trial of Consolidation Targeted Adjuvant Therapy with Encorafenib and Cetuximab versus Usual Care for Patients with Stage II/III BRAF V600E Colon Cancer
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
A022101
|
Alliance
|
A Pragmatic Randomized Phase III Trial Evaluating Total Ablative Therapy for Patients with Limited Metastatic Colorectal Cancer: Evaluating Radiation, Ablation, and Surgery (ERASur)
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
A022102
|
Alliance
|
Randomized Phase III trial of mFOLFIRINOX +/- Nivolumab vs. FOLFOX +/- Nivolumab for First-Line Treatment of Metastatic HER2-Negative Gastroesophageal Adenocarcinoma
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
A022104
|
Alliance
|
The Janus Rectal Cancer Trial: A Randomized Phase II Trial Testing the Efficacy of Triplet versus Doublet Chemotherapy to Achieve Clinical Response in Patients with Locally Advanced Rectal Cancer
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
A022106
|
Alliance
|
Phase II/III Second-Line NABPLAGEM vs. Nab-Paclitaxel/Gemcitabine in BRCA1/2 or PALB2 Mutant Metastatic Pancreatic Ductal Adenocarcinoma (PLATINUM)
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|